Most of the kidney failure patients in the present study harbored SNPs of CYP3A4, CYP3A5, MDR1 C3435T, and MDR1 G2677T, that could affect tacrolimus dose requirement in transplant recipients. This evidence concerns the gene CYP3A5 and kidney failure.